Alt: a boy in a blue shirt is standing on a chair in front of a classroom full of children and dancing.

This post explores the human decisions needed in implementing AI at organizations.

Today's post explores issues facing scholarly publishers around AI — using it, layering it, competing against it, and licensing to it.

Despite accounting for over 8% of the global population and bearing a growing cancer burden, Latin America (LATAM) contributes <2% of global oncology trial activity and scientific output. Beyond…

Academia built entire careers on a free Google service with zero guarantees. What could go wrong?

NCI funding policy for research project grant (RPG) awards reflects the funding goals of the institute, NIH, and HHS.

The move would undo years of work, leaving advisory councils understaffed, and without the full expertise needed for reviews.

The ASCO Annual Meeting is the Society's yearly gathering where oncologists unveil their latest clinical research, and ASCO Daily News has you covered before, during, and after the Meeting with in-dep...

ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without extraneous information.

PURPOSEOver the course of the COVID-19 pandemic, the Food and Drug Administration allowed cancer clinical trials to make modifications. As policymakers consider sustaining these modifications, underst...

PURPOSEClinical trials are integral for patients with cancer but remain inaccessible to many because of barriers including geographic and transportation challenges. This study aimed to evaluate cancer...

Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly discussed the role of ...

PURPOSEOver the course of the COVID-19 pandemic, the Food and Drug Administration allowed cancer clinical trials to make modifications. As policymakers consider sustaining these modifications, underst...